Qanatpharma
PrivateLast Round
VC Round
Jul 1, 2023
Company Overview
Qanatpharma is a clinical-stage biopharmaceutical company that develops innovative therapies for diseases characterized by microvascular dysfunction.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qanatpharma Comparables
Compare Qanatpharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aphaia Pharma | 36% | |
| HeartBeat.bio AG | 33% | |
| Variant Bio | 33% |
Qanatpharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 1, 2023 |
Key People
Founding team and executive leadership
Steffen-Sebastian Bolz
Executive Board Member And Chief Scientific And Medical Officer, Founder
Qanatpharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ventura BioMed Investors | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 5, 2026
Grew 30% quarter-over-quarter, from 10 to 13 employees.
- Jan 1, 2026
Monthly visitors grew 320% MoM, from 10 to 42.
Qanatpharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Qanatpharma's valuation, stock price, and market status.
Is Qanatpharma a public or private company?
Qanatpharma is a private company.
What is the current stock price of Qanatpharma?
Qanatpharma is a private company with no public stock price. No recent secondary market data is available.
How much is Qanatpharma worth (valuation)?
Valuation information for Qanatpharma is not publicly available.
Can I buy Qanatpharma stock?
Qanatpharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Qanatpharma's last funding round?
Qanatpharma's most recent funding round was VC Round on July 1, 2023.
Who are the main investors in Qanatpharma?
Key investors in Qanatpharma include Ventura BioMed Investors.
Will Qanatpharma IPO soon?
No public IPO plans have been announced for Qanatpharma.
How can I track Qanatpharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Qanatpharma's secondary market activity and sign up for updates.